CAS: 59804-37-4; 4-Hydroxy-2-Methyl-N-(Pyridin-2-yl)-2H-Thieno[2,3-E][1,2]Thiazine-3-Carboxamide 1,1-Dioxide

该化合物是一种非类固醇抗炎药物,主要用于其止痛和抗炎特性,其特点是能够抑制环氧酶酶(COX-1和COX-2),它在合成蛋白腺炎,炎症和疼痛的媒介方面发挥着关键作用;Tenoxicam一般是口服的,因其长半衰期而闻名,允许一次日服;该物质是一种黄晶状粉,其分子配方反映其复杂的结构,包括一种硫氨环;在水中表现出中度溶解性,在有机溶剂中更加溶解;Tenoxicam经常被规定为诸如骨质炎,风湿气类炎和急性疼痛等症状的合成;虽然有效,但它也可能具有副作用,包括胃肠道问题和潜在的心血管风险,需要谨慎的病人监测;其具有可塑性能和感应变能;其感应变能和感应变能,在治疗中需要谨慎地进行其感应变力和感性能.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号504-29-0 2-氨基吡啶 | CAS号59804-25-0 替诺昔康甲化物 | CAS号59337-89-2 3-氯噻吩-2-羧酸 | CAS号59337-92-7 3-(氯磺酰)-2-噻吩羧酸甲酯 | CAS号59337-91-6 3-chlorosulfony... | CAS号98827-44-2 替诺昔康环合物 | CAS号106820-63-7 3-磺酰氨基乙酸甲酯-2-噻吩甲酸甲酯 | CAS号59804-24-9 methyl 3-[[N-[(... | CAS号504-29-0 2-氨基吡啶

合成工艺路线路线简述

    Methyl 3-<<(Ethoxycarbonyl)Methyl>-N-Methylamino>Sulfonyl>-2-Thiophenecarboxylate置于sodium Methylate体系中,用 甲醇,Xylene 作为反应溶剂,化学反应 7.67H,反应生成 替诺昔康
    参考文献:Analogs And Derivatives Of Tenoxicam. 1. Synthesis And Antiinflammatory Activities Of Analogs With Different Residues On The Ring Nitrogen And The Amide Nitrogen
    标题:Analogs And Derivatives Of Tenoxicam. 1. Synthesis And Antiinflammatory Activities Of Analogs With Different Residues On The Ring Nitrogen And The Amide Nitrogen
    摘要:The Synthesis Of Tenoxicam,4-Hydroxy-2-Methyl-N-2-Pyridyl-2H-Thieno[2,3-E]-1,2-Thiazine-3-Carboxami De 1,1-Dioxide (1E),And Of The Analogues With Various Residues On The Ring Nitrogen And The Amide Nitrogen Is Described. This New Class Of "Oxicams" Has Pronounced Antiinflammatory And Analgesic Properties. The Very Specific Structure-Activity Relationship Of Isomeric And Isosteric Groups At The Amide Nitrogen Has Been Evaluated. The Substituent In Position 2 Also Has A Great Influence On The Pharmacological Properties. Tenoxicam Is Presently Undergoing Clinical Trials.
    DOI:10.1021/jm00387A017

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-8546532-B2
    优先权日:2008-04-17
    标题:Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
    发明人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS
    权利人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS; DECLION PHARMACEUTICALS INC
    摘要:The instant invention comprises a process for the solid phase synthesis of directed epitope peptide mixtures useful in the treatment and diagnosis of protein conformational disorders, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition is a mixture of related peptides for therapeutic use. The invention also pertains to the process of generating antibodies using the directed epitope peptide mixtures as the antigens, and antibodies generated by such process, useful in the treatment and diagnostics of the said protein conformational disorder.

    专利号:US-2017132357-A1
    优先权日:2015-11-10
    标 题 :Platform for visual synthesis of genomic, microbiome, and metabolome data
    发明人:BREWERTON SUZANNE; COON BRYAN; XIE CHAO; Zuniga Rafael; DE CASTRO JHALLEY; Yooseph Shibu; LI WEIZHONG; ULASZEK RYAN; KLITGORD NIELS; YEO ZHENXUAN; Mulawadi Fabi; FRIEDMAN AARON; TERRELL STEPHEN; WIRAWAN ADRIANTO; Gule Korkut; Saygi Erhan; HADIMULYONO ANDREAS; Tan Yong Heng; Sisk Thomas; VOLOCHENKO ALEXEY; BLAIR SEAN; ANG AIK MENG; LIM KIAN YONG; ZHANG DANIEL; Bezyazychnyy Dmitry; WANG QIANG; LIU XIAOHUI; Lim Ream; Veshkurtsev Nikita; Wong Marie; PIPER JASON; SUN MIAO; CLONEY MATTHEW; PHAM BAO; TURPAZ YARON
    权利人:HUMAN LONGEVITY INC
    摘要:Described are platforms, systems, media, and methods for providing a biologic information visual synthesis application, the biologic information including one or more of: genome data, microbiome data, and metabolome data.

    专利号:US-7332505-B2
    优先权日:1999-02-26
    标 题 :Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
    发明人:GARVEY DAVID S; LETTS L GORDON; RICHARDSON STEWART K; TAM SANG WILLIAM; WANG TIANSHENG
    权利人:NITROMED INC
    摘要:The present invention describes novel nitrosated and/or nitrosylated proton pump inhibitor compounds, and novel compositions comprising at least one proton pump inhibitor compound that is optionally substituted with at least one NO and/or NO 2 group, and, optionally, at least one compound that donates, transfers, or releases nitric oxide, induces the production of endogenous nitric oxide or endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase, and/or at least one nonsteroidal antiinflammatory drug, selective COX-2 inhibitor, antacid, bismuth-containing reagent, acid-degradable antibacterial compound, and mixtures thereof. The present invention also provides methods for treating and/or preventing gastrointestinal disorders; facilitating ulcer healing; decreasing the recurrence of ulcers; improving gastroprotective properties, anti- Helicobacter pylon properties or antacid properties of proton pump inhibitors; decreasing or reducing the gastrointestinal toxicity associated with the use of nonsteroidal antiinflammatory compounds; treating Helicobacter pylori and viral infections. The compounds and/or compositions of the present invention can also be provided in the form of a pharmaceutical kit.

    专利号:US-9051302-B2
    优先权日:2008-01-15
    标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
    发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
    权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
    摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

    专利号:US-2013035307-A1
    优先权日:2010-01-26
    标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
    发明人:PRESTWICH GLENN D; KENNEDY THOMAS P
    权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P
    摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.
    常州市兰明科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.lmkjcz.com
    企业联系电话:0519-88816918👤
    📞常州市兰明科技有限公司 ⚠️参考联系方式
    联系人:白朝明,白磊
    电话:0519-88816918
    手机:13906110072;13915000734
    传真:0519-88255676
    邮箱:lmkj@lmkjcz.com
    通信地址: 江苏省常州市采菱路7号
    邮编: 213018
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市采菱路7号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏联环药业集团公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.lhpharma.com
    电话: 0514-87814842 87829556👤
    📞江苏联环药业集团公司 ⚠️参考联系方式

    销售电话:0514-87814842 87829556
    邮箱:xsb@lhpharma.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    安徽星宇化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pyridinechem.com
    电话:0555-2568883;👤
    📞 安徽星宇化工有限公司⚠️参考联系方式

    电话: 0555-2568883;
    邮件:jvd@pyridinechem.com
    网址: http://www.pyridinechem.com
    地址:安徽和县乌江镇安徽省精细化工园区
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    安徽和县乌江镇安徽省精细化工园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北威德利化学科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.widelychemical.com
    企业联系电话:13385289472👤
    📞湖北威德利化学科技有限公司 ⚠️参考联系方式
    联系人:赵方
    电话:13385289472
    手机:13385289472
    传真:027- 59222918
    邮箱:z13385289472@163.com
    通信地址: 湖北省武汉市硚口区解放大道204号
    邮编: 430033
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市硚口区解放大道204号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州优联医药化工公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.unipharma-chem.com
    企业联系电话:0571-85803833;56766020👤
    📞杭州优联医药化工公司 ⚠️参考联系方式
    联系人:顾元伟
    电话:0571-85803833;56766020

    传真:0571-85803855
    邮箱:info@unipharma-chem.com
    通信地址: 浙江省杭州市朝晖路203号深蓝广场办公楼1109室
    邮编: 310010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市朝晖路203号深蓝广场办公楼1109室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Girard P, Chauvin M, Verleye M. Nefopam analgesia and its role in multimodal analgesia: A review of preclinical and clinical studies. Clin Exp Pharmacol Physiol. 2016 Jan;43(1):3-12. doi: 10.1111/1440-1681.12506. Review. doi: 10.1002/14651858.CD008659.pub3. Review. doi: 10.1002/14651858.CD010120.pub2. Review. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127-46. doi: 10.2165/11633470-000000000-00000. Review.
    5: Salat K, Moniczewski A, Librowski T. Nitrogen, oxygen or sulfur containing heterocyclic compounds as analgesic drugs used as modulators of the nitroxidative stress. Mini Rev Med Chem. 2013 Mar;13(3):335-52. Review. doi: 10.1002/14651858.CD005277.pub3. Review. doi: 10.1002/14651858.CD006378.pub2. Review. doi: 10.1002/14651858.CD008659.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;9:CD008659.
    9: Xiaoting L, Yin T, Yangxi C. Interventions for pain during fixed orthodontic appliance therapy. A systematic review. Angle Orthod. 2010 Sep;80(5):925-32. doi: 10.2319/010410-10.1. Review. doi: 10.1213/ANE.0b013e3181cdb081. Epub 2010 Mar 23. Review. doi: 10.1213/ANE.0b013e3181cf9281. Epub 2010 Feb 8. Review. doi: 10.1002/14651858.CD007591.pub2. Review.

    合成参考文献


    摘要:Iyakuhin Kenkyu. Study of Medical Supplies., 18(1030), 1987
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    摘要:S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (2021) DOI:10.1021/acsenvironau.1c00008. List downloaded from
    参考文献:10.1007/bf01728332
    摘要:Legras A, Piquemal R, Furet Y, Dequin PF, Perrotin D. Buflomedil poisoning: five cases with cardiotoxicity. Intensive Care Med. 1996 Jan;22(1):57–61. doi: 10.1007/bf01728332.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知